Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...

View the most recent dividend declared by the scheme in the last 30 days along with its value.